Filter posts

BIO Principles on Expanded Access to Investigational, Unapproved Medicines

Seriously ill patients with limited or no alternative therapies, and who are ineligible or unable …

Dr. Petra Kaufmann Video Interview: Clinical and Translational Science Awards Program

Petra Kaufmann, MD, MSc, Director of the Division of Clinical Innovation at the National Institutes …

Coalition Offers a Remedy for Stagnated Clinical Trials

Promising new clinical trial data offers fresh hope for the families of Alzheimer’s patients.  A …

What to Watch: Emperor of All Maladies; Killing Cancer

Cancer is a disease which affects almost 1.7 million people each year in America, and …

Webinar Today: Comparative Effectiveness Research

As we continue to see new strides in biopharmaceutical innovation, there is increasing value in …

My Path From the BioGENEius Challenge to the White House Science Fair

My name is Natalie Ng, winner of the 2013 International BioGENEius Challenge, and I am …

Blue Ribbon Study Panel Examines Surveillance and Detection Issues in Biodefense

The Blue Ribbon Study Panel on Biodefense held the third of four meetings on Thursday, …

Celebrating the Biomedical Achievements on World Down Syndrome Day

Guest Post by Sara Hart Weir, MS, President, National Down Syndrome Society On March 21, we celebrate …

CDC Report: C. diff Infections Associated with 29,000 Deaths per Year in US; Vaccines Could Provide ...

Last month, the CDC released a new study on the impact of microbial super bug …

The Value of Innovation to Save and Transform Lives

Patients have greater hope for cures to today’s most complex and challenging diseases thanks to …